Molecular Stamping S.r.l., a Trento, Italy-based company focused on the development and commercialization of genetic analysis assays produced using its proprietary Supramolecular Nanostamping technology, closed a $2m funding round.
Investors include two backers from the Trentino Alto Adige region: La Finanziaria Trentina S.p.A. and Enthofin S.r.l. which join Innogest Capital, an Italian venture capital fund and other existing investors.
Based in Trento at the Fondazione Bruno Kessler research institute, Molecular Stamping is a subsidiary of California-based TwoF Inc.
Founded in 2006, the firm’s focus is the development and the commercialization of research started by Prof. Francesco Stellacci on Nanotechnologies and Material Sciences at the Massachusetts Institute of Technology.
The company, which currently employs 14 highly skilled people, of whom several have PhDs in biology or chemistry, is led by Giovanni De Ceglia, a manager with high profile experience at global technology leaders such as Texas Instruments, Cisco and Pirelli.